Full Access
Bronchopulmonary dysplasia
D. I. TUDEHOPE,
D. I. TUDEHOPE
Director of Neonatology Mater Misericordiae Mothers' Hospital South Brishbane, Qld 4101 Australia
Search for more papers by this authorD. I. TUDEHOPE,
D. I. TUDEHOPE
Director of Neonatology Mater Misericordiae Mothers' Hospital South Brishbane, Qld 4101 Australia
Search for more papers by this author
REFERENCES
- 1 Northway W. H., Rosan R., Porter D. Y. Pulmonary disease following respiratory therapy of hyaline membrane disease and broncho-pulmonary dysplasia. N. Engl. J. Med. 1967; 276: 357–68.
- 2 Edwards D. K. Radiographic aspects of bronchopulmonary dysplasia. J. Pediatr. 1979; 95: 823–9.
- 3 Hyde I., English R. E., Williams J. D. The changing pattern of chronic lung disease of prematurity. Arch. Dis. Child. 1989; 64: 448–51.
- 4 Tooley W. H. Epidemiology of bronchopulmonary dysplasia. J. Pediatr. 1979; 95: 851–5.
- 5 Bancalari E., Abdenour G. E., Feller R., Gannon J. Bronchopulmonary dysplasia: clinical presentation. J. Pediatr. 1979; 85: 819–23.
- 6 Shennan A. T., Dunn M. S., Ohlsson A., Lennan K., Hoskins E. M. Abnormal pulmonary outcomes in premature infants: Prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82: 527–32.
- 7 Boynton B. R. The epidemiology of bronchopulmonary dysplasia. In T. A. Merritt, W. H. Northway, B. R. Boynton eds. Bronchopulmonary Dysplasia. Blackwell Scientific Publications, Oxford . 1988: 19–32.
- 8 Hack M., Horbar J. D., Malloy M. H., Tyson T. E., Wright E., Wright L. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Network. Pediatrics 1991; 87: 587–97.
- 9 Northway W. H. Bronchopulmonary dysplasia: then and now. Arch. Dis. Child. 1990; 65: 1076–81.
- 10 Frank L., Bucher J. R., Roberts R. J. Oxygen toxicity in neonatal and adult animals of various species. J. Appl. Physiol. 1978; 45: 699–704.
- 11 Watson E. D., Henderson-Smart D. J., Storey G. N. B., Peat B., Grattan-Smith P. Perinatal factors and the development of chronic lung disease in preterm infants: A case control study. Aust. Paediatr. J. 1987; 23: 181–4.
- 12 Nickerson B. G., Taussig L. M. Family history of asthma in infants with bronchopulmonary dysplasia. Pediatrics 1980; 65: 1140.
- 13 Brown E. R., Stark A., Sosenko I., Lawson E. E., Avery M. E. Bronchopulmonary dysplasia: possible relationship to pulmonary oedema. J. Pediatr. 1978; 92: 982–4.
- 14 Spitzer A. R., Fox W. W., Delivoria-Papadopoulos M. Maximum diuresis—a factor in predicting recovery from respiratory distress syndrome. J. Pediatr. 1981; 98: 476–9.
- 15 Van Marten L. J., Levitan A., Allred E. N., Papano M., Kuban K. C. K. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. J. Pediatr. 1990; 116: 942–9.
- 16 Ehrenkranz R. A., Mercurio M. R. Bronchopulmonary dysplasia. In J. C. Sinclair, M. B. Bracken eds. Effective Care of the Newborn. Oxford University Press, Oxford . 1992; 401–2.
- 17 Rosenfeld W., Evans H., Concepcion L., Jhaveri R., Shaeffer H., Fredinan A. Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome. J. Pediatr. 1984; 105: 781–5.
- 18 Shenai J. P., Kennedy K. A., Chytil F., Stahlman M. T. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J. Pediatr. 1987; 111: 269–77.
- 19 Papagaroufalis C., Cavis M., Pantazatou E., Megieli C. H., Xanthou M. A. A trial of vitamin A supplementation for the prevention of bronchopulmonary dysplasia in very low birth weight infants. Pediatr. Res. 1988; 23: 518A.
- 20 Hallman M., Bry K., Hoppu K., Lappi M., Pohjavuori M. Inositol supplementation in premature infants with respiratory distress syndrome. N. Engl. J. Med. 1992; 326: 1233–9.
- 21 Liggins G. C., Howie R. N. A controlled trial of antepartum gluco-steroid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515–25.
- 22 Crowley P. Promoting pulmonary maturity. In I. Chalmers, M. Enkin, M. J. N. C. Keirse Effective Care in Pregnancy and Childbirth. Oxford University Press, Oxford . 1989; 746–64.
- 23 Doyle L. W., Kitchen W. H., Ford G. W., Rickards A. L., Lissenden J. V., Ryan M. M. Effects of antenatal steroid therapy on mortality and morbidity in very low birth weight infants. J. Pediatr. 1986; 108: 287–92.
- 24 Van Marten L. J., Leviton A., Kuban K. C. K., Papane M., Allred E. N. Maternal glucocorticosteroid therapy and reduced risk of broncho-pulmonary dysplasia. Pediatrics 1990; 86: 331–6.
- 25 Ballard R. A., Ballard P. L., Creasy R. K. et al. Respiratory disease in very low birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. Lancet 1992; 339: 510–15.
- 26 Soll R. F., McQueen M. C. Respiratory distress syndrome. In J. C. Sinclair, M. B. Bracken eds. Effective Care of the Newborn Infant. Oxford University Press, Oxford . 1992.
- 27 HIFI Study Group. High frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. N. Engl. J. Med. 1989; 320: 88–93.
- 28 Avery M. E., Tooley W. H., Keller J. B. et al. Is chronic lung disease in low birthweight infants preventable? A survey of 8 centres. Pediatrics 1987; 79: 26–30.
- 29 Yeh T. F., Luken J. A., Thalji A., Raval D., Carr I., Pildes R. S. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus—a double-blind controlled study. J. Pediatr. 1981; 98: 137–45.
- 30 Gersony W. M., Peckham G. J., Ellison R. C., Miettinen O. S. Patent ductus arteriosus: Results of a national collaborative study. J. Pediatr. 1983; 102: 895–906.
- 31 Sanchez P. J., Regan J. A. Ureaplasma urealyticum colonization and chronic lung disease in low birth weight infants. Pediatr. Infect. Dis. J. 1988; 7: 542–6.
- 32 Kao L. C., Warburton D., Sargent C. W., Platzker A. C. G., Keens T. G. Furosemide acutely decreases airways resistance in chronic broncho-pulmonary dysplasia. J. Pediatr. 1983; 103: 624–9.
- 33 McCann E. M., Lewis K., Doming D. D., Donovan M. J., Brady J. P. Controlled trial of furosemide therapy in infants with chronic lung disease. J. Pediatr. 1985; 106: 957–62.
- 34 Albersheim S. G., Solimano A. J., Sharma A. K. et al. Randomized, double-blind, controlled trial of long-term diuretic therapy in broncho-pulmonary dysplasia. J. Pediatr. 1989; 115: 615–20.
- 35 Kao L. C., Warburton D., Platzker A. C. G., Keens T. G. Effect of isoproterenol inhalation on airway resistance in chronic broncho-pulmonary dysplasia. Pediatrics 1984; 73: 509–14.
- 36 Gomez-Del Rio M., Gerhardt T., Hehre D., Feller R., Bancalari E. Effect of a beta-agonist nebulization on lung function in neonates with increased pulmonary resistance. Pediatr. Pulmonol. 1986; 2: 287–91.
- 37 Kao L. C., Durand D. J., Birch M. A., Phillips B. L., Nickerson B. G. Metaproterenol and atropine aerosols improve pulmonary mechanics in infants with bronchopulmonary dysplasia (BPD). Pediatr. Res. 1987; 21: 456A.
- 38 Wilkie R. A., Bryan M. H. Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease. J. Pediatr. 1987; 111: 278–82.
- 39 Kramer L. I., Hulzen C. The role of steroids in early bronchopulmonary dysplasia (BPD). Pediatr. Res. 1978; 12: 564A.
- 40 Avery G. B., Fletcher A. B., Kaplan M., Brudno D. S. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 1985; 75: 106–11.
- 41 Cummings J. J., D'Eugenio D. B., Gross S. J. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N. Engl. J. Med. 1989; 320: 1505–10.
- 42 Ohlsson A., Calvert S., Hosking M., Shennan A. Randomized controlled trial of dexamethasone treatment in very low birthweight infants with ventilator dependent chronic lung disease. Pediatr. Res. 1989; 25: 225A.
- 43 Harkavy K. L., Scanlon J. W., Chowdhry P. K., Grylack L. J. Dexamethasone therapy for chronic lung disease in ventilator and oxygen-dependent infants: A controlled trial. J. Pediatr. 1989; 115: 979–83.
- 44 Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: An international placebo-controlled trial. Pediatrics 1991; 88: 421–7.
- 45 Gray P. H., Grice J. F., Lee M., Ritchie B. H., Williams G. Prediction of outcome of preterm infants with severe bronchopulmonary dysplasia. J. Paediatr. Child Health 1992; 28: 107–112.
- 46 Mayes L., Perkett E., Stahlman M. T. Severe bronchopulmonary dysplasia: a retrospective review. Acta Paediatr. Scand. 1983; 72: 225–9.
- 47 Sauve R. S., Singhal N. Long term morbidity of infants with bronchopulmonary dysplasia. Pediatrics 1985; 76: 725–33.
- 48 Shankevan S., Szego E., Eizert D., Siegel P. Severe bronchopulmonary dysplasia: predictors of survival and outcome. Chest 1984; 86: 607–10.
- 49 Markestad T., Fitzhardinge P. M. Growth and development in children recovering from BPD. J. Pediatr. 1981; 98: 597–602.